[HTML][HTML] SIRT3 and cancer: tumor promoter or suppressor?
TY Alhazzazi, P Kamarajan, E Verdin… - Biochimica et Biophysica …, 2011 - Elsevier
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2011•Elsevier
Abstract Sirtuins (SIRT1–7), the mammalian homologues of the Sir2 gene in yeast, have
emerging roles in age-related diseases, such as cardiac hypertrophy, diabetes, obesity, and
cancer. However, the role of several sirtuin family members, including SIRT1 and SIRT3, in
cancer has been controversial. The aim of this review is to explore and discuss the
seemingly dichotomous role of SIRT3 in cancer biology with particular emphasis on its
potential role as a tumor promoter and tumor suppressor. This review will also discuss the …
emerging roles in age-related diseases, such as cardiac hypertrophy, diabetes, obesity, and
cancer. However, the role of several sirtuin family members, including SIRT1 and SIRT3, in
cancer has been controversial. The aim of this review is to explore and discuss the
seemingly dichotomous role of SIRT3 in cancer biology with particular emphasis on its
potential role as a tumor promoter and tumor suppressor. This review will also discuss the …
Abstract
Sirtuins (SIRT1–7), the mammalian homologues of the Sir2 gene in yeast, have emerging roles in age-related diseases, such as cardiac hypertrophy, diabetes, obesity, and cancer. However, the role of several sirtuin family members, including SIRT1 and SIRT3, in cancer has been controversial. The aim of this review is to explore and discuss the seemingly dichotomous role of SIRT3 in cancer biology with particular emphasis on its potential role as a tumor promoter and tumor suppressor. This review will also discuss the potential role of SIRT3 as a novel therapeutic target to treat cancer.
Elsevier